Total Funding
49
Total FundingGrant raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
109249
Stratatech develops cell-based and tissue-engineered skin substitute products for therapeutic and research applications.
Russell R. Smestad: President
Cindy Ballweg: Director Finance & Administration and Treasurer
About the Company
Stratatech Corporation, a regenerative medicine company, engages in the development and commercialization of cell-based and tissue-engineered skin substitute products for therapeutic and research applications. The company specializes in human tissue substitutes generated with NIKS keratinocytes and cells derived from them for biological therapies.
Its products include StrataGraft skin tissue, a temporary wound cover that promotes wound healing by the patient's own cells and improve the wound bed to receive autografts; and ExpressGraft skin tissue, a genetically enhanced tissue that produces various levels of natural wound healing and antimicrobial factors. The company was founded in 2000 and is based in Madison, Wisconsin.
